People: Tornier NV (TRNX.O)

TRNX.O on Nasdaq

25.46USD
26 Dec 2014
Price Change (% chg)

$-0.22 (-0.86%)
Prev Close
$25.68
Open
$25.72
Day's High
$25.83
Day's Low
$25.45
Volume
52,166
Avg. Vol
480,124
52-wk High
$28.53
52-wk Low
$16.68

Search Stocks

Mowry, David 

Brief Biography

Mr. David H. Mowry is President, Chief Executive Officer of Tornier N.V. since February 21, 2013. He joined the Company in July 2011 as Chief Operating Officer and in November 2012 was appointed Interim President and Chief Executive Officer and, effective as of February 21, 2013, was appointed President and Chief Executive Officer on a non-interim basis. He has over 24 years of experience in the medical device industry. Prior to joining the Company, Mr. Mowry served from July 2010 to July 2011 as the President of the Global Neurovascular Division of Covidien plc, a global provider of healthcare products. From January 2010 to July 2010, Mr. Mowry served as Senior Vice President and President, Worldwide Neurovascular of ev3 Inc., a global endovascular device company acquired by a wholly owned subsidiary of Covidien Group S.a.r.l in July 2010. From August 2007 to January 2010, Mr. Mowry served as Senior Vice President of Worldwide Operations of ev3. Prior to this position, Mr. Mowry was Vice President of Operations for ev3 Neurovascular from November 2006 to October 2007. Before joining ev3, Mr. Mowry served as Vice President of Operations and Logistics at the Zimmer Spine division of Zimmer Holdings Inc., a reconstructive and spinal implants, trauma and related orthopaedic surgical products company, from February 2002 to November 2006. Prior to Zimmer, Mr. Mowry was the President and Chief Operating Officer of HeartStent Corp., a medical device company. Mr. Mowry is a graduate of the United States Military Academy in West Point, New York with a degree in Engineering and Mathematics.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
359,257 -- 237,732 789,619

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Sean Carney

--

David Mowry

789,619

Kevin O'Boyle

--

Shawn McCormick

906,603

Terry Rich

1,654,300

Gordon Van Ummersen

--
As Of 29 Dec 2012
Search Stocks